[1]
A. Batta, K. Hazarika, D. Varshney, and R. Gugnani, “Comparison of the efficacy and safety of hydroxychloroquine versus teneligliptin as add on therapy in uncontrolled type 2 diabetes mellitus: a randomized, prospective and open labelled study”, Int J Basic Clin Pharmacol, vol. 15, no. 2, pp. 276–282, Feb. 2026.